Home
Conditions
Proteostasis Deficiencies

Clinical trial condition

Proteostasis Deficiencies

Explore clinical trials studying Proteostasis Deficiencies. Study availability and eligibility vary by location and protocol.

1,351 public trials 352 recruiting studies

Refine in advanced search Browse all conditions

Proteostasis Deficiencies trial results

Not Yet Recruiting

Investigation of Cannabinoid 2-receptor Expression in the Brain and Spine of ALS-patients Compared to Healthy Controls With PET (18F-RoSMALS)

NCT05880563

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations: Muskelzentrum/ALS-Clinic, Kantonsspital St. Gallen Sankt Gallen, Switzerland

View Trial Details

Completed

Efficacy of [18F]Florbetaben PET for Diagnosis of Cardiac AL Amyloidosis

NCT05184088

Conditions: AL Amyloidosis, ATTR Amyloidosis, Amyloid Neuropathies, +23 more
Locations: St Luke's Hospital Kansas City, Kansas, United States

University of Pennsylvania Philadelphia, Pennsylvania, United States

University of Pittsburgh Pittsburgh, Pennsylvania, United States

University of Augsburg Augsburg, Germany

View all 14 locations

View Trial Details

Completed

A Study of Belantamab Mafodotin in Patients With Relapsed or Refractory AL Amyloidosis

NCT04617925

Conditions: AL Amyloidosis, Amyloidosis, Immune System Diseases, +10 more
Locations: Centre hospitalier Universitaire de Limoges - Limoges, France

University Hospital Heidelberg Heidelberg, Germany

General Hospital of Athens "Alexandra" Athens, Greece

Fondazione I.R.C.C.S Policlinico "San Matteo" Pavia, Italy

View Trial Details

Completed

Natural History and Biomarkers of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Caused by the C9ORF72 Gene Mutation

NCT01925196

Conditions: Amyotrophic Lateral Sclerosis, Brain Diseases, Central Nervous System Diseases, +14 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Completed

Trial of Oral Digoxin in Individuals With Amyotrophic Lateral Sclerosis (ALS)

NCT07047209

Conditions: ALS (Amyotrophic Lateral Sclerosis), Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, +9 more
Locations: Nova Southeastern University Davie, Florida, United States

Northwestern Universsity Chicago, Illinois, United States

MGH Boston, Massachusetts, United States

View Trial Details

Completed

Plasmapheresis in Amyotrophic Lateral Sclerosis With Autoantibody Against NRIP

NCT05562960

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +9 more
Locations: National Taiwan University Hospital Taipei, Taiwan

View Trial Details

Completed

Efficacy and Safety Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis (ALS)

NCT00330681

Conditions: Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Central Nervous System Diseases, +9 more
Locations: Not specified

View Trial Details

Completed

Efficacy and Safety Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis (ALS) Who Met Severity Classification III

NCT00415519

Conditions: Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Central Nervous System Diseases, +9 more
Locations: Not specified

View Trial Details

Completed

Phase 3 Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis

NCT01492686

Conditions: Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Central Nervous System Diseases, +9 more
Locations: Osaka, Japan

View Trial Details

Completed

HIBA-Institutional Registry of Amyloidosis

NCT01347047

Conditions: Amyloidosis, Disease Attributes, Metabolic Diseases, +5 more
Locations: Hospital Italiano de Buenos Aires Buenos Aires, Argentina

View Trial Details

Proteostasis Deficiencies

Proteostasis Deficiencies trial results

Related conditions